FBXW2 and breast cancer: Further, Kaplan–Meier (KM) plot of The Cancer Genome Atlas (TCGA) datasets suggests that higher expression levels of FBXW2 are strongly associated with better recurrence-free survival (RFS) in breast cancer patients whereas higher expression levels of Moesin are strongly associated with poor patient RFS (Fig. 1F, G).